Subscribe

Brenntag SE (BNR.DE)

EUR59.96 +1.70 (+2.92%)
DE XETRA Basic Materials Chemicals - Specialty
Address Messeallee 11 45131
Essen, DE
CEO Jens Birgersson
Website brenntag.com
IPO 2010-03-29
ISIN DE000A1DAHH0

Explore sections of this company profile

Also trades on Deutsche Börse · BNR.DE (EUR) Other OTC · BNTGF (USD) Other OTC · BNTGY (USD) Swiss Exchange · BNR.SW (CHF)
Description

Brenntag SE functions as a premier global distributor for a vast selection of industrial and specialty chemicals and ingredients. Its comprehensive network extends across Europe, the Middle East & Africa, North and Latin America, and the Asia Pacific region. The company structures its operations through two distinct divisions: Brenntag Essentials and Brenntag Specialties. Beyond its core distribution services, Brenntag delivers crucial value-added support, including timely 'just-in-time' deliveries, custom product blending and mixing, repackaging solutions, efficient inventory management, and responsible drum return programs. For its specialty chemical clients, it also provides advanced technical and laboratory assistance. Brenntag SE caters to a wide array of end-market sectors, encompassing nutrition, pharmaceuticals, personal care, water treatment, and lubricants, in addition to serving the home, industrial, and institutional markets, as well as the coatings, construction, polymers, and rubber industries. Founded in 1874, the company's headquarters are located in Essen, Germany.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
EUR59.96 +1.70 (+2.92%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
338.4K
Beta
0.51
Float Shares
115.36M
Free Float %
79.9%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-0.39% +0.26% +3.58% +6.86% +27.28% +23.82% +2.33% -18.22% -19.21% +29.62% +241.11%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
59.96
DCF (Unlevered) 110.64 +84.5%
DCF (Levered) 112.87 +88.2%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 29% Bullish
Rating 2026-05 Change
Strong Buy 0 -1
Buy 4 0
Hold 7 0
Sell 2 -1
Strong Sell 1 -1
Quality scores
Altman Z-Score
2.98
Grey zone
Piotroski F-Score
6 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
5 / 5
High
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
2 / 5
Medium
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
  • ✗
    Revenue growth Chemicals - Specialty: +4.7%
    -6.6% Q1'26: -10.1% (vs Q1'25)
  • ✗
    EPS growth Chemicals - Specialty: +13.2%
    -50.7% Q1'26: -26.9% (vs Q1'25)
  • ✓
    FCF margin FCF growth · Chemicals - Specialty: +44.1%
    +3.6% Q1'26: +2.0% (vs Q1'25)
  • ✗
    EBIT margin Chemicals - Specialty: +8.8%
    +4.8% Q1'26: +4.9% (vs Q1'25)
  • ✗
    ROIC Chemicals - Specialty: +5.6%
    +6.5% ★ Q1'26: +6.7% (vs Q1'25)
  • ✓
    Share dilution Chemicals - Specialty: +0.1%
    -0.2% ★ Q1'26: -0.1% (vs Q1'25)
  • ✗
    Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×
    2.82× Q1'26: 2.97× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.53) × ERP
WACC = 73% × Ke + 27% × Kd (4.2%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 109.34 Current price: 59.96
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2011
actual 		Dec 2012
actual 		Dec 2013
actual 		Dec 2014
actual 		Dec 2015
actual 		Dec 2016
actual 		Dec 2017
actual 		Dec 2018
actual 		Dec 2019
actual 		Dec 2020
actual 		Dec 2021
actual 		Dec 2022
actual 		Dec 2023
actual 		Dec 2024
actual 		Dec 2025
actual 		Dec 2026
10 Rev. Ana.
9 EPS Ana. 		Dec 2027
13 Rev. Ana.
10 EPS Ana. 		Dec 2028
9 Rev. Ana.
6 EPS Ana. 		Dec 2029
4 Rev. Ana.
4 EPS Ana. 		Dec 2030
4 Rev. Ana.
2 EPS Ana.
Revenue
8.68B
est: 8.74B (-0.7%)
9.69B
est: 9.77B (-0.8%)
9.77B
est: 10.02B (-2.5%)
10.02B
est: 10.11B (-0.9%)
10.35B
est: 10.41B (-0.6%)
10.50B
est: 10.48B (+0.1%)
11.74B
est: 11.63B (+1.0%)
12.55B
est: 12.52B (+0.2%)
12.82B
est: 12.90B (-0.6%)
11.78B
est: 11.81B (-0.3%)
14.38B
est: 13.70B (+5.0%)
19.43B
est: 18.98B (+2.4%)
16.82B
est: 16.21B (+3.7%)
16.24B
est: 16.34B (-0.7%)
15.17B
est: 15.30B (-0.9%)
15.17B
15.02B – 15.41B
-0.9% YoY
15.69B
15.03B – 16.64B
+3.4% YoY
16.31B
16.30B – 16.33B
+4.0% YoY
16.03B
15.61B – 16.65B
-1.7% YoY
17.00B
16.55B – 17.66B
+6.0% YoY
EBITDA
638.50M
est: 271.79M (+134.9%)
703.00M
est: 446.87M (+57.3%)
712.60M
est: 543.23M (+31.2%)
716.70M
est: 580.58M (+23.4%)
782.40M
est: 590.18M (+32.6%)
771.60M
est: 591.80M (+30.4%)
773.90M
est: 644.25M (+20.1%)
876.30M
est: 636.93M (+37.6%)
1.01B
est: 721.14M (+40.5%)
995.90M
est: 762.86M (+30.5%)
1.03B
est: 799.43M (+28.4%)
1.70B
est: 836.39M (+103.1%)
1.51B
est: 1.32B (+14.3%)
1.33B
est: 1.36B (-1.9%)
1.16B
est: 1.24B (-7.1%)
1.23B
1.22B – 1.25B
-0.9% YoY
1.28B
1.22B – 1.35B
+3.4% YoY
1.33B
1.33B – 1.33B
+4.0% YoY
1.30B
1.27B – 1.35B
-1.7% YoY
1.38B
1.35B – 1.44B
+6.0% YoY
EBIT
525.50M
est: 465.88M (+12.8%)
569.90M
est: 609.98M (-6.6%)
571.70M
est: 598.38M (-4.5%)
581.40M
est: 556.65M (+4.4%)
620.80M
est: 618.51M (+0.4%)
609.90M
est: 672.95M (-9.4%)
612.40M
est: 708.02M (-13.5%)
706.70M
est: 666.09M (+6.1%)
721.30M
est: 744.90M (-3.2%)
700.20M
est: 657.01M (+6.6%)
709.20M
est: 688.51M (+3.0%)
1.33B
est: 720.33M (+84.8%)
1.12B
est: 932.52M (+19.9%)
888.00M
est: 960.24M (-7.5%)
733.20M
est: 880.27M (-16.7%)
872.50M
864.09M – 886.76M
-0.9% YoY
902.44M
864.49M – 957.27M
+3.4% YoY
938.39M
937.39M – 939.39M
+4.0% YoY
922.23M
898.21M – 958.03M
-1.7% YoY
977.72M
952.25M – 1.02B
+6.0% YoY
Net Income
279.30M
est: 164.03M (+70.3%)
336.20M
est: 309.46M (+8.6%)
339.20M
est: 350.27M (-3.2%)
339.30M
est: 339.40M (0.0%)
365.00M
est: 354.73M (+2.9%)
360.30M
est: 371.15M (-2.9%)
360.80M
est: 394.10M (-8.4%)
460.90M
est: 388.18M (+18.7%)
466.70M
est: 476.18M (-2.0%)
466.50M
est: 427.71M (+9.1%)
448.30M
est: 448.22M (+0.0%)
886.80M
est: 752.80M (+17.8%)
714.90M
est: 602.60M (+18.6%)
536.20M
est: 668.08M (-19.7%)
264.60M
est: 484.14M (-45.3%)
494.65M
454.35M – 672.20M
+2.2% YoY
595.08M
464.88M – 777.68M
+20.3% YoY
704.09M
607.35M – 837.45M
+18.3% YoY
724.17M
699.64M – 760.71M
+2.9% YoY
816.45M
788.81M – 857.66M
+12.7% YoY
SGA
1.24B
est: 1.44B (-13.8%)
1.38B
est: 1.39B (-1.2%)
1.41B
est: 1.44B (-1.8%)
1.46B
est: 1.41B (+3.6%)
1.63B
est: 1.53B (+6.1%)
1.74B
est: 1.66B (+4.8%)
1.87B
est: 1.91B (-2.1%)
1.92B
est: 2.01B (-4.7%)
2.05B
est: 1.98B (+3.3%)
2.07B
est: 1.88B (+10.4%)
382.90M
est: 1.97B (-80.5%)
507.60M
est: 2.06B (-75.3%)
586.10M
est: 673.84M (-13.0%)
662.20M
est: 693.88M (-4.6%)
1.21B
est: 636.09M (+89.5%)
630.47M
624.39M – 640.78M
-0.9% YoY
652.11M
624.68M – 691.73M
+3.4% YoY
678.09M
677.36M – 678.81M
+4.0% YoY
666.41M
649.05M – 692.28M
-1.7% YoY
706.50M
688.10M – 733.93M
+6.0% YoY
EPS
1.80
est: 1.88 (-4.4%)
2.17
est: 2.18 (-0.4%)
2.20
est: 2.16 (+2.0%)
2.20
est: 2.28 (-3.5%)
2.36
est: 2.58 (-8.4%)
2.33
est: 2.47 (-5.6%)
2.34
est: 2.64 (-11.2%)
2.98
est: 2.96 (+0.6%)
3.02
est: 3.09 (-2.2%)
3.02
est: 3.13 (-3.5%)
2.90
est: 4.25 (-31.7%)
5.74
est: 6.44 (-10.9%)
4.73
est: 4.11 (+15.1%)
3.71
est: 4.59 (-19.1%)
1.83
est: 3.33 (-45.0%)
3.73
3.15 – 4.66
+12.0% YoY
4.23
3.22 – 5.39
+13.5% YoY
4.77
4.21 – 5.80
+12.9% YoY
5.02
4.85 – 5.27
+5.1% YoY
5.65
5.46 – 5.94
+12.7% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-12 B+ 3/5 5/5 3/5 4/5 1/5 2/5 3/5
2026-05-11 B+ 3/5 5/5 3/5 4/5 1/5 2/5 3/5
2026-05-08 B+ 3/5 5/5 3/5 4/5 1/5 2/5 3/5
2026-05-07 B+ 3/5 5/5 3/5 4/5 1/5 2/5 3/5
2026-05-06 B+ 3/5 5/5 3/5 4/5 1/5 2/5 3/5
2026-05-05 B+ 3/5 5/5 3/5 4/5 1/5 2/5 3/5
2026-05-04 B+ 3/5 5/5 3/5 4/5 1/5 2/5 3/5
2026-04-30 B+ 3/5 5/5 3/5 5/5 1/5 2/5 3/5
2026-04-29 B+ 3/5 5/5 3/5 5/5 1/5 2/5 3/5
2026-04-28 B+ 3/5 5/5 3/5 5/5 1/5 2/5 3/5
2026-04-27 B+ 3/5 5/5 3/5 5/5 1/5 2/5 3/5
2026-04-24 B+ 3/5 5/5 3/5 5/5 1/5 2/5 3/5
2026-04-23 B+ 3/5 5/5 3/5 5/5 1/5 2/5 3/5
2026-04-22 B+ 3/5 5/5 3/5 5/5 1/5 2/5 3/5
2026-04-21 B+ 3/5 5/5 3/5 5/5 1/5 2/5 3/5
2026-04-20 B+ 3/5 5/5 3/5 5/5 1/5 2/5 3/5
2026-04-17 B+ 3/5 5/5 3/5 5/5 1/5 2/5 3/5
2026-04-16 B+ 3/5 5/5 3/5 5/5 1/5 2/5 3/5
2026-04-15 B+ 3/5 5/5 3/5 5/5 1/5 2/5 3/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
544.09M
OE per share TTM
3.76
Owner's Yield
6.08%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
12.2%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
40.5K
Shares Outstanding
144.39M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Jens Birgersson Chairman of the Management Board & Chief Executive Officer 2M male
Thomas Reisten Chief Financial Officer & Member of the Management Board 1M male
Thomas Altmann Senior Vice President of Investor Relations — male
Ursula Baumgartner-Durchschlag Head of Laboratory & Qualified Person — female
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Chemicals - Specialty